UM-Myeloma-Genomics/Genomic-and-immune-signatures-predict-clinical-outcome-in-newly-diagnosed-myeloma

Code for defining malignant plasma cells using copy number variation in single cell RNA sequencing and performing the RNAseq pathway enrichment analysis.

R